Tagged: PMP

Intraperitoneal Mitomycin C Improves Survival in PMP

Acredit co-founder Professor Kjersti Flatmark and colleagues have published new findings showing that the use of mitomycin C with intraperitoneal chemotherapy (IPEC) during cytoreductive surgery doubled survival times and reduced tumour growth in a...

Acredit Network Conference at Losby Gods

The Norwegian Acredit Network group members met to learn a little more about one another’s research at Losby Gods Hotel (Norway) on the 2nd to 3rd November. Topics covered included everything from “What is...

Cure4PMP Meeting – Paris

L to R (seated): Wim (Belgium), Sarah (Belgium), Emel (Turkey), Nagane (France), Annette (Norway), Christin (Norway), Yvonne (Norway); L to R (standing): Mirshahi (France), Kusamura (Italy), Marc (France), Clarisse (France), Amandine (France), Kjersti (Norway)....

PSOGI 2016

PSOGI 2016

Various ACREDIT members participated in the PSOGI 2016 International congress held 17-19 November 2016 in Washington, D.C. Yvonne Andersson (pictured right), presented a poster showing results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I...

Cure4PMP Network Meeting, Washington

Cure4PMP Network Meeting, Washington

The Cure4PMP network met during the PSOGI Conference in Washington DC. After an update on PMP pathology, existing biobanks/availability of samples and molecular analyses, the possibility to apply for a COST action was discussed,...

Cure4PMP Meeting, Brussels

Cure4PMP Meeting, Brussels

  At the first Cure4PMP Partner Meeting in Brussels on 11th of September 2015, various issues concerning the consortium was discussed. First an update of the call draft SC1-PM-03–2017 in H2020 “Diagnostic characterisation of...